Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro

Tuberculosis (TB) continues being one of the diseases having the greatest mortality rates around the world, 8.7 million cases having been reported in 2011. An efficient vaccine against TB having a great impact on public health is an urgent need. Usually, selecting antigens for vaccines has been base...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2014
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23650
Acceso en línea:
https://doi.org/10.1111/cbdd.12365
https://repository.urosario.edu.co/handle/10336/23650
Palabra clave:
BCG vaccine
Lipoprotein
Mycobacterium tuberculosis lipoprotein Rv1411c
Mycobacterium tuberculosis lipoprotein Rv1911c
Mycobacterium tuberculosis lipoprotein Rv2270
Mycobacterium tuberculosis lipoprotein Rv3763
Unclassified drug
Antibody
Bacterial protein
Lipoprotein
Microsphere
Peptide
Protein binding
A549 cell line
Amino acid sequence
Article
Bacterial membrane
Bacterial virulence
Controlled study
Epithelium cell
Host pathogen interaction
Human
In vitro study
Mycobacterium tuberculosis
Nonhuman
Protein expression
Protein localization
Protein structure
Target cell
U937 cell line
Biology
Chemistry
Host pathogen interaction
Immunology
Metabolism
Molecular genetics
Mycobacterium tuberculosis
Protein secondary structure
Synthesis
Tumor cell line
Mycobacterium tuberculosis
Amino Acid Sequence
Antibodies
Bacterial Proteins
Computational Biology
Host-Pathogen Interactions
Humans
Lipoproteins
Microspheres
Molecular Sequence Data
Mycobacterium tuberculosis
Peptides
Protein Binding
U937 Cells
Antituberculosis vaccine
High activity binding peptide
Multi-epitope vaccine
Mycobacterium tuberculosis
Synthetic peptide
Tumor
Secondary
Cell Line
Protein Structure
Rights
License
Abierto (Texto Completo)
id EDOCUR2_aae7d5b67a984837842552d7b03b04f9
oai_identifier_str oai:repository.urosario.edu.co:10336/23650
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 5184882660091225589-151721018-179653065-110ecd4f9-843f-4ef2-bec0-7d39d3381a13-12020-05-26T00:04:02Z2020-05-26T00:04:02Z2014Tuberculosis (TB) continues being one of the diseases having the greatest mortality rates around the world, 8.7 million cases having been reported in 2011. An efficient vaccine against TB having a great impact on public health is an urgent need. Usually, selecting antigens for vaccines has been based on proteins having immunogenic properties for patients suffering TB and having had promising results in mice and non-human primates. Our approach has been based on a functional approach involving the pathogen-host interaction in the search for antigens to be included in designing an efficient, minimal, subunit-based anti-TB vaccine. This means that Mycobacterium tuberculosis has mainly been involved in studies and that lipoproteins represent an important kind of protein on the cell envelope which can also contribute towards this pathogen's virulence. This study has assessed the expression of four lipoproteins from M. tuberculosis H37Rv, that is, Rv1411c (LprG), Rv1911c (LppC), Rv2270 (LppN) and Rv3763 (LpqH), and the possible biological activity of peptides derived from these. Five peptides were found for these proteins which had high specific binding to both alveolar A549 epithelial cells and U937 monocyte-derived macrophages which were able to significantly inhibit mycobacterial entry to these cells in vitro. © 2014 John Wiley and Sons A/S.application/pdfhttps://doi.org/10.1111/cbdd.1236517470277https://repository.urosario.edu.co/handle/10336/23650engBlackwell Publishing Ltd641No. 6626Chemical Biology and Drug DesignVol. 84Chemical Biology and Drug Design, ISSN:17470277, Vol.84, No.6 (2014); pp. 626-641https://www.scopus.com/inward/record.uri?eid=2-s2.0-84915819376&doi=10.1111%2fcbdd.12365&partnerID=40&md5=0573841866c487b00b4657ecd9f2db97Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURBCG vaccineLipoproteinMycobacterium tuberculosis lipoprotein Rv1411cMycobacterium tuberculosis lipoprotein Rv1911cMycobacterium tuberculosis lipoprotein Rv2270Mycobacterium tuberculosis lipoprotein Rv3763Unclassified drugAntibodyBacterial proteinLipoproteinMicrospherePeptideProtein bindingA549 cell lineAmino acid sequenceArticleBacterial membraneBacterial virulenceControlled studyEpithelium cellHost pathogen interactionHumanIn vitro studyMycobacterium tuberculosisNonhumanProtein expressionProtein localizationProtein structureTarget cellU937 cell lineBiologyChemistryHost pathogen interactionImmunologyMetabolismMolecular geneticsMycobacterium tuberculosisProtein secondary structureSynthesisTumor cell lineMycobacterium tuberculosisAmino Acid SequenceAntibodiesBacterial ProteinsComputational BiologyHost-Pathogen InteractionsHumansLipoproteinsMicrospheresMolecular Sequence DataMycobacterium tuberculosisPeptidesProtein BindingU937 CellsAntituberculosis vaccineHigh activity binding peptideMulti-epitope vaccineMycobacterium tuberculosisSynthetic peptideTumorSecondaryCell LineProtein StructureSpecific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitroarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Ocampo, MarisolCurtidor, HernandoVanegas, MagnoliaPatarroyo, Manuel A.Patarroyo, Manuel E.10336/23650oai:repository.urosario.edu.co:10336/236502022-05-02 07:37:21.184751https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
title Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
spellingShingle Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
BCG vaccine
Lipoprotein
Mycobacterium tuberculosis lipoprotein Rv1411c
Mycobacterium tuberculosis lipoprotein Rv1911c
Mycobacterium tuberculosis lipoprotein Rv2270
Mycobacterium tuberculosis lipoprotein Rv3763
Unclassified drug
Antibody
Bacterial protein
Lipoprotein
Microsphere
Peptide
Protein binding
A549 cell line
Amino acid sequence
Article
Bacterial membrane
Bacterial virulence
Controlled study
Epithelium cell
Host pathogen interaction
Human
In vitro study
Mycobacterium tuberculosis
Nonhuman
Protein expression
Protein localization
Protein structure
Target cell
U937 cell line
Biology
Chemistry
Host pathogen interaction
Immunology
Metabolism
Molecular genetics
Mycobacterium tuberculosis
Protein secondary structure
Synthesis
Tumor cell line
Mycobacterium tuberculosis
Amino Acid Sequence
Antibodies
Bacterial Proteins
Computational Biology
Host-Pathogen Interactions
Humans
Lipoproteins
Microspheres
Molecular Sequence Data
Mycobacterium tuberculosis
Peptides
Protein Binding
U937 Cells
Antituberculosis vaccine
High activity binding peptide
Multi-epitope vaccine
Mycobacterium tuberculosis
Synthetic peptide
Tumor
Secondary
Cell Line
Protein Structure
title_short Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
title_full Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
title_fullStr Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
title_full_unstemmed Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
title_sort Specific interaction between mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits Mycobacterial entry in vitro
dc.subject.keyword.spa.fl_str_mv BCG vaccine
Lipoprotein
Mycobacterium tuberculosis lipoprotein Rv1411c
Mycobacterium tuberculosis lipoprotein Rv1911c
Mycobacterium tuberculosis lipoprotein Rv2270
Mycobacterium tuberculosis lipoprotein Rv3763
Unclassified drug
Antibody
Bacterial protein
Lipoprotein
Microsphere
Peptide
Protein binding
A549 cell line
Amino acid sequence
Article
Bacterial membrane
Bacterial virulence
Controlled study
Epithelium cell
Host pathogen interaction
Human
In vitro study
Mycobacterium tuberculosis
Nonhuman
Protein expression
Protein localization
Protein structure
Target cell
U937 cell line
Biology
Chemistry
Host pathogen interaction
Immunology
Metabolism
Molecular genetics
Mycobacterium tuberculosis
Protein secondary structure
Synthesis
Tumor cell line
Mycobacterium tuberculosis
Amino Acid Sequence
Antibodies
Bacterial Proteins
Computational Biology
Host-Pathogen Interactions
Humans
Lipoproteins
Microspheres
Molecular Sequence Data
Mycobacterium tuberculosis
Peptides
Protein Binding
U937 Cells
Antituberculosis vaccine
High activity binding peptide
Multi-epitope vaccine
Mycobacterium tuberculosis
Synthetic peptide
topic BCG vaccine
Lipoprotein
Mycobacterium tuberculosis lipoprotein Rv1411c
Mycobacterium tuberculosis lipoprotein Rv1911c
Mycobacterium tuberculosis lipoprotein Rv2270
Mycobacterium tuberculosis lipoprotein Rv3763
Unclassified drug
Antibody
Bacterial protein
Lipoprotein
Microsphere
Peptide
Protein binding
A549 cell line
Amino acid sequence
Article
Bacterial membrane
Bacterial virulence
Controlled study
Epithelium cell
Host pathogen interaction
Human
In vitro study
Mycobacterium tuberculosis
Nonhuman
Protein expression
Protein localization
Protein structure
Target cell
U937 cell line
Biology
Chemistry
Host pathogen interaction
Immunology
Metabolism
Molecular genetics
Mycobacterium tuberculosis
Protein secondary structure
Synthesis
Tumor cell line
Mycobacterium tuberculosis
Amino Acid Sequence
Antibodies
Bacterial Proteins
Computational Biology
Host-Pathogen Interactions
Humans
Lipoproteins
Microspheres
Molecular Sequence Data
Mycobacterium tuberculosis
Peptides
Protein Binding
U937 Cells
Antituberculosis vaccine
High activity binding peptide
Multi-epitope vaccine
Mycobacterium tuberculosis
Synthetic peptide
Tumor
Secondary
Cell Line
Protein Structure
dc.subject.keyword.eng.fl_str_mv Tumor
Secondary
Cell Line
Protein Structure
description Tuberculosis (TB) continues being one of the diseases having the greatest mortality rates around the world, 8.7 million cases having been reported in 2011. An efficient vaccine against TB having a great impact on public health is an urgent need. Usually, selecting antigens for vaccines has been based on proteins having immunogenic properties for patients suffering TB and having had promising results in mice and non-human primates. Our approach has been based on a functional approach involving the pathogen-host interaction in the search for antigens to be included in designing an efficient, minimal, subunit-based anti-TB vaccine. This means that Mycobacterium tuberculosis has mainly been involved in studies and that lipoproteins represent an important kind of protein on the cell envelope which can also contribute towards this pathogen's virulence. This study has assessed the expression of four lipoproteins from M. tuberculosis H37Rv, that is, Rv1411c (LprG), Rv1911c (LppC), Rv2270 (LppN) and Rv3763 (LpqH), and the possible biological activity of peptides derived from these. Five peptides were found for these proteins which had high specific binding to both alveolar A549 epithelial cells and U937 monocyte-derived macrophages which were able to significantly inhibit mycobacterial entry to these cells in vitro. © 2014 John Wiley and Sons A/S.
publishDate 2014
dc.date.created.spa.fl_str_mv 2014
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:04:02Z
dc.date.available.none.fl_str_mv 2020-05-26T00:04:02Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1111/cbdd.12365
dc.identifier.issn.none.fl_str_mv 17470277
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23650
url https://doi.org/10.1111/cbdd.12365
https://repository.urosario.edu.co/handle/10336/23650
identifier_str_mv 17470277
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 641
dc.relation.citationIssue.none.fl_str_mv No. 6
dc.relation.citationStartPage.none.fl_str_mv 626
dc.relation.citationTitle.none.fl_str_mv Chemical Biology and Drug Design
dc.relation.citationVolume.none.fl_str_mv Vol. 84
dc.relation.ispartof.spa.fl_str_mv Chemical Biology and Drug Design, ISSN:17470277, Vol.84, No.6 (2014); pp. 626-641
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84915819376&doi=10.1111%2fcbdd.12365&partnerID=40&md5=0573841866c487b00b4657ecd9f2db97
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Blackwell Publishing Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167679519424512